Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$93.7K Buy
76,600
+45,900
+150% +$3.05M 0.01% 504
2025
Q2
$116K Buy
+30,700
New +$1.84M 0.01% 412
2020
Q4
Sell
-20,600
Closed -$74K 2315
2020
Q3
$74K Sell
20,600
-5,000
-20% -$316K ﹤0.01% 867
2020
Q2
$79K Buy
+25,600
New +$1.26M ﹤0.01% 909
2017
Q1
Sell
-25,200
Closed -$4K 1148
2016
Q4
$4K Buy
25,200
+200
+0.8% +$7.72K ﹤0.01% 903
2016
Q3
$18K Buy
+25,000
New +$944K ﹤0.01% 894
2015
Q4
Sell
-12,300
Closed -$2K 1015
2015
Q3
$2K Buy
+12,300
New +$488K ﹤0.01% 998
2015
Q2
Sell
-11,000
Closed -$18K 1063
2015
Q1
$18K Buy
+11,000
New +$338K ﹤0.01% 735

Other funds holding HOLX

HAP Trading's HOLX Position: Q1 2022 in Review

HAP Trading sold out of Hologic (HOLX) in Q1 2022, closing a stake of 10,829 shares — an estimated $829K sold.

HAP Trading first reported a position in HOLX in Q2 2013 and held it in 6 quarters. The position peaked at $1.11M in Q3 2021. 700 funds tracked by Wall St. Rank hold HOLX as of Q1 2022.

  • HAP Trading reported no remaining Hologic position as of Q1 2022 after selling out during the quarter.
  • HAP Trading sold 10,829 Hologic shares in Q1 2022, an estimated $829K.
  • HAP Trading first reported a position in Hologic in Q2 2013 and held it in 6 quarters.
  • HAP Trading's Hologic position peaked at $1.11M in Q3 2021.
  • 700 funds tracked by Wall St. Rank held Hologic as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.